Subtopic Deep Dive

Deubiquitinating Enzymes Mechanisms
Research Guide

What is Deubiquitinating Enzymes Mechanisms?

Deubiquitinating enzymes (DUBs) are proteases that hydrolyze ubiquitin from target proteins, reversing ubiquitination signals through specific catalytic mechanisms.

DUBs feature diverse catalytic domains including USP, UCH, OTU, MJD, JAMM, and MINDY families that cleave ubiquitin chains at linkages like K48, K63, or M1. Research details chain editing, specificity determinants, and regulation by allosteric factors (Mevissen and Komander, 2017, 989 citations). Over 90 human DUBs participate in proteostasis and signaling reversal.

Curated Papers

Key Challenges

Why It Matters

DUB inhibitors target cancer proteostasis defects, such as USP7 inhibition in p53 pathway restoration (Harrigan et al., 2017). They counter pathogen DUBs in infections by blocking host deubiquitination (Swatek and Komander, 2016). Therapeutic screening expands ubiquitin modulators beyond E3 ligases, addressing neurodegeneration via proteostasis recovery (Labbadia and Morimoto, 2015; Ciechanover and Kwon, 2015).

Key Research Challenges

DUB Specificity Determination

DUBs select ubiquitin linkages like K48 for degradation reversal or K63 for signaling, but structural basis varies across 90+ enzymes (Mevissen and Komander, 2017). Allosteric regulation complicates prediction. High-throughput assays lag for topology-specific cleavage.

Inhibitor Selectivity Development

Designing reversible DUB inhibitors faces off-target effects on homologous active sites (Harrigan et al., 2017). Cellular redundancy requires polypharmacology. Screening identifies hits but clinical translation stalls (Swatek and Komander, 2016).

Chain Topology Recognition

DUBs edit complex polyubiquitin signals including branched chains, but mechanisms remain unclear beyond K48/K63 (Thrower, 2000). Structural dynamics hinder modeling. In vivo validation lacks high-resolution tools.

Essential Papers

Ubiquitin modifications

Kirby N. Swatek, David Komander · 2016 · Cell Research · 2.0K citations

The <scp>BioGRID</scp> database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions

Rose Oughtred, Jennifer Rust, Christie Chang et al. · 2020 · Protein Science · 1.8K citations

Abstract The BioGRID (Biological General Repository for Interaction Datasets, thebiogrid.org ) is an open‐access database resource that houses manually curated protein and genetic interactions from...

Recognition of the polyubiquitin proteolytic signal

Julia S. Thrower · 2000 · The EMBO Journal · 1.7K citations

The Biology of Proteostasis in Aging and Disease

Johnathan Labbadia, Richard I. Morimoto · 2015 · Annual Review of Biochemistry · 1.4K citations

Loss of protein homeostasis (proteostasis) is a common feature of aging and disease that is characterized by the appearance of nonnative protein aggregates in various tissues. Protein aggregation i...

Mechanisms of Deubiquitinase Specificity and Regulation

Tycho E.T. Mevissen, David Komander · 2017 · Annual Review of Biochemistry · 989 citations

Protein ubiquitination is one of the most powerful posttranslational modifications of proteins, as it regulates a plethora of cellular processes in distinct manners. Simple monoubiquitination event...

Deubiquitylating enzymes and drug discovery: emerging opportunities

Jeanine A. Harrigan, Xavier Jacq, Niall M.B. Martin et al. · 2017 · Nature Reviews Drug Discovery · 889 citations

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies

Aaron Ciechanover, Yong Tae Kwon · 2015 · Experimental & Molecular Medicine · 858 citations

Abstract Mammalian cells remove misfolded proteins using various proteolytic systems, including the ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and macroautophagy. Th...

Reading Guide

Foundational Papers

Start with Thrower (2000, 1679 citations) for polyubiquitin signal basics; Tanaka (2009, 838 citations) on proteasome context; Varshavsky (2011, 720 citations) for N-end rule ties to DUB reversal.

Recent Advances

Mevissen and Komander (2017, 989 citations) for specificity mechanisms; Harrigan et al. (2017, 889 citations) on drug discovery; Bard et al. (2018, 788 citations) for proteasome-DUB interfaces.

Core Methods

X-ray crystallography for active sites (Swatek and Komander, 2016); activity-based probes for inhibitors (Harrigan et al., 2017); BioGRID for networks (Oughtred et al., 2020).

How PapersFlow Helps You Research Deubiquitinating Enzymes Mechanisms

Discover & Search

Research Agent uses searchPapers for 'deubiquitinating enzyme mechanisms USP7 specificity' yielding Mevissen and Komander (2017); citationGraph traces 989 backlinks to Swatek and Komander (2016); findSimilarPapers expands to Harrigan et al. (2017) inhibitors.

Analyze & Verify

Analysis Agent applies readPaperContent on Mevissen and Komander (2017) to extract catalytic domain structures; verifyResponse with CoVe cross-checks linkage specificity claims against Thrower (2000); runPythonAnalysis parses BioGRID interaction data (Oughtred et al., 2020) for DUB networks with GRADE scoring evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in K63-editing inhibitors via contradiction flagging across Harrigan et al. (2017) and Swatek and Komander (2016); Writing Agent uses latexEditText for mechanism diagrams, latexSyncCitations for 10-paper bibliography, latexCompile for review draft; exportMermaid visualizes DUB cascade topologies.

Use Cases

"Analyze DUB interaction networks from BioGRID for USP7 inhibitors"

Research Agent → searchPapers 'BioGRID DUB interactions' → Analysis Agent → runPythonAnalysis (pandas network graph on Oughtred et al., 2020 data) → matplotlib centrality plot of USP7 hubs.

"Write LaTeX review on OTU DUB chain editing mechanisms"

Synthesis Agent → gap detection on Mevissen and Komander (2017) → Writing Agent → latexEditText (insert mechanisms) → latexSyncCitations (add Thrower 2000) → latexCompile → PDF with ubiquitin topology figure.

"Find GitHub code for DUB high-throughput screening simulations"

Research Agent → paperExtractUrls (Harrigan et al., 2017) → paperFindGithubRepo → githubRepoInspect → code for inhibitor docking models exported via exportCsv.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'DUB catalytic mechanisms', structures report with sections on families (USP/OTU) citing Mevissen and Komander (2017). DeepScan applies 7-step CoVe to verify inhibitor claims from Harrigan et al. (2017) against proteostasis papers (Labbadia and Morimoto, 2015). Theorizer generates hypotheses on JAMM DUB regulation from citationGraph of Swatek and Komander (2016).

Try Doxa for Deubiquitinating Enzymes Mechanisms Research

Frequently Asked Questions

What defines deubiquitinating enzymes?

DUBs are cysteine or metallo-proteases that remove ubiquitin from substrates or chains via catalytic domains like USP or JAMM (Mevissen and Komander, 2017).

What are key methods for DUB research?

Structural biology reveals active sites; high-throughput screens identify inhibitors; linkage-specific assays probe topologies (Swatek and Komander, 2016; Harrigan et al., 2017).

What are seminal papers on DUB mechanisms?

Mevissen and Komander (2017, 989 citations) details specificity; Swatek and Komander (2016, 1962 citations) covers modifications; Thrower (2000, 1679 citations) on polyubiquitin signals.

What open problems exist in DUB mechanisms?

Branched chain editing lacks models; in vivo allostery uncharted; selective inhibitors for redundant DUBs needed (Mevissen and Komander, 2017; Harrigan et al., 2017).